JNJ vs BMY
Johnson & Johnson vs Bristol Myers Squibb — AI-powered side-by-side comparison
| Metric | JNJ | BMY |
|---|---|---|
| AI Score | 64 | 60 |
| Price | $256.93 | $57.56 |
| P/E Ratio | 29.74× | 19.93× |
| ROE | 26.3% | 41.6% |
| Revenue Growth YoY | 7.9% | 1.8% |
| Gross Margin | 68.0% | 53.7% |
| Debt / Equity | 0.59× | 2.44× |
| Dividend Yield | 2.1% | 4.3% |
| RSI (14) | 55.5 | 53.8 |
| Beta | 0.2291 | 0.235 |
| Expected Upside | — | +4.6% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
JNJ Full Analysis
BMY Full Analysis